Does low free and bioavailable testosterone with normal SHBG indicate reduced testosterone production?

In postmenopausal health, understanding the interplay between total testosterone, its carrier proteins, and the biologically active fraction is essential for assessing androgen status. When sex hormone-binding globulin (SHBG) remains within normal physiological ranges, the dynamics of testosterone transport are stable, shifting the clinical focus to the body's androgen production capacity.

Clinical and physiological evidence

When SHBG levels are normal, the distribution of testosterone between bound and free states follows predictable equilibrium dynamics. Because SHBG is the primary high-affinity transporter for testosterone, a stable (normal) SHBG concentration means the "binding reservoir" is neither expanded nor depleted.

• In this state, the free and bioavailable testosterone fractions become mathematically and physiologically dependent on the total testosterone (TT) concentration.
• Data from postmenopausal cohorts indicate that if TT is low and SHBG is normal, the resulting low free testosterone is a direct consequence of low total circulating androgens rather than an abnormality in protein binding.

Mechanistic explanations

The relationship between SHBG and testosterone is defined by the law of mass action.

• Binding dynamics: SHBG binds testosterone with high affinity, while albumin binds it with low affinity. If SHBG levels are normal, the binding capacity of the blood is constant. Therefore, there is no "excess binding" to sequestrate the hormone.
• Production vs. sequestration: Low total testosterone in postmenopausal women typically results from the involution of the ovaries and age-related changes in adrenal precursor production (DHEA/DHEAS).
• Androgen source: Because the binding environment is stable (normal SHBG), a low free testosterone level serves as a reliable marker for decreased glandular output—primarily from the ovaries and the peripheral conversion of adrenal precursors.

Clinical implications

For a 57-year-old female, this biochemical profile clarifies the origin of androgen deficiency.

• A normal SHBG rules out common confounders that artificially lower free testosterone, such as hyperinsulinemia or obesity (which lower SHBG) or hyperthyroidism and high estrogen states (which raise SHBG).
• The findings suggest that clinical symptoms of androgen deficiency in this context are tied to a primary production deficit rather than a transport issue.

Bottom line

When SHBG is normal, the levels of free and bioavailable testosterone are a direct reflection of total hormone production. In this scenario, low free testosterone confirms a primary deficit in androgen synthesis—typically related to ovarian or adrenal changes—rather than an increase in hormone sequestration by binding proteins.